INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

This adverse event was reported 117261 times

These drugs are most commonly taken by patients reporting INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION:

# Drug Count
0 ADAPALENE 15840
1 INSULIN GLARGINE 8308
2 INFLIXIMAB 6209
3 PREDNISONE 6170
4 DUPILUMAB 5929
5 ACETAMINOPHEN 5478
6 INFLIXIMAB-DYYB 5048
7 SALICYLIC ACID 4734
8 SECUKINUMAB 4394
9 METHOTREXATE SODIUM 4295
See all common drugs associated with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INFLIXIMAB-DYYB 5048 0.2484
1 DOLUTEGRAVIR SODIUM AND LAMIVUDINE 244 0.1209
2 COAL TAR 67 0.1149
3 AZATHIOPRINE SODIUM 154 0.0990
4 BENZOYL PEROXIDE 593 0.0987
5 BUROSUMAB 490 0.0968
6 CANAKINUMAB 886 0.0943
7 SALICYLIC ACID 4734 0.0928
8 AVOBENZONE, OCTISALATE, AND OCTOCRYLENE 87 0.0925
9 ADAPALENE 15840 0.0917
See all drugs enriched for association with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION